Can psychedelic-assisted psychotherapy play a role in enhancing motivation to change in addiction treatment settings?

Existing treatments for substance use disorders, including medications and psychosocial interventions, have significant shortcomings such as low retention and high relapse rates. Psychedelic-assisted psychotherapies are re-emerging as promising adjunctive treatments for addiction and other mental health conditions, but there is a lack of validated metrics to evaluate recovery capital and motivation to change—a crucial factor in positive treatment outcomes. This commentary describes the current state of research and the potential of psychedelic-assisted psychotherapy to enhance motivation to change in addiction treatment, and emphasizes the need for validated tools to assess whether these therapies can produce lasting improvements in substance use behaviors.

Study at a glance

Abstract

Abstract Despite growing availability of several evidence-based approaches in the treatment of substance use disorders, existing pharmacotherapy and psychosocial interventions continue to have significant limitations, such as low treatment retention rates and high rates of relapse. There is a need to develop new strategies and models to address these limitations and target underlying psychosocial drivers of addiction, such as motivation to change – a crucial factor in achieving positive addiction treatment outcomes. Re-emerging clinical evidence and literature signal the promise of psychedelic-assisted psychotherapies as being novel, adjunctive treatments for a range of mental health and substance use disorders, encouraging further research. However, there remains a lack of formally validated metrics to evaluate recovery capital and motivation, limiting interpretation of the growing psychedelic literature. This commentary describes the current state of this line of investigation and potential impact of psychedelic-assisted psychotherapy on enhancing motivation to change in addiction treatment, and the need for validated metrics to evaluate recovery motivation and capital to assess the potential for psychedelic-assisted psychotherapies to elicit positive, lasting changes in substance use behaviors among those seeking treatment.